PRagmatic EVAluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD.
Recruiting
Pragmatic Evaluation of a Quality Improvement Program for People Living With Modifiable High-risk COPD (PREVAIL)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
As a cluster randomized controlled trial, participants in PREVAIL are the Primary Care Teams. The PREVAIL CRT adopts the definition of PCT from the Agency for Healthcare Research and Quality, "a group of primary care practice personnel who identify as members of a team and who work together to provide care for a panel of patients." Inclusion Criteria: * Primary Care Teams (PCTs) must be able to function as a single randomization unit with low risk of contamination between participants and physicians due to the absence of blinding in the intervention (see section 8.8 for details on blinding). * PCT must have a sufficient number of patients meeting modifiable high-risk patient criteria (see section 8.1 on sample size estimates). * PCT must express willingness to be randomized to either receive the CONQUEST program initially, or usual care until program roll-out to the delayed intervention arm. Exclusion Criteria: * PCTs that are in the process of, or planning to change EHR software provider or practice ownership within the trial outcome evaluation period * PCTs engaged in active research studies or COPD related Quality Improvement Programs which might impact the ability to implement CONQUEST program.
About the study
A 3-year cluster randomized controlled trial of the impact of a quality improvement and clinical decision support package versus usual care for patients with modifiable high-risk chronic obstructive pulmonary disease with or without a current diagnosis.
What is being tested
- CONQUEST Quality Improvement Program (other)
Sponsor: Observational and Pragmatic Research Institute · Participants: 126 · Started: Sep 23, 2022
Contact the study team
- David Price, FRCGP · Phone: +65 3105 1489
Official record on ClinicalTrials.gov — NCT05306743
Locations in the U.S.
| Colorado | University of Colorado, Denver |
| New York | Mount Sinai, New York |
| Ohio | MetroHealth, Cleveland |
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.